BiotechTube
Home/Tempo Therapeutics/Kwame Ulmer
KU

Kwame Ulmer

Chief Regulatory Officer

Tempo Therapeutics

Therapeutic Areas

Surgical OncologySoft Tissue ReconstructionWound Healing

Tempo Therapeutics Pipeline

DrugIndicationPhase
MAP Biosurgery Product (e.g., TT101)Soft tissue reconstruction (Dermal and Abdominal Wall)Pre-clinical

Leadership Team at Tempo Therapeutics

WW
Westbrook Weaver, PhD
Founder & CEO
DG
Donald Griffin, PhD
Founder & CSO
SD
Stephanie Deshayes, PhD
VP R&D
TS
Tatiana Segura, PhD
Founder, Scientific Advisor
View full Tempo Therapeutics profile